• 1
    Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343:26980.
  • 2
    Adcock IM, Ito K, Barnes PJ. Glucocorticoids. Effects on gene transcription. Proc Am Thorac Soc 2004; 1:24754.
  • 3
    Soriano JB, Zhang X, Camp PG et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest 2007; 131:6829.
  • 4
    Barnes PJ. Corticosteroid resistance in airway disease. Proc Am Thorac Soc 2004; 1:2648.
  • 5
    Di Stefano A, Capelli A, Lusuardi M et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:127785.
  • 6
    Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:264553.
  • 7
    Culpitt SV, Rogers DF, Shah P et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:2431.
  • 8
    Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004; 200:68995.
  • 9
    Barnes PJ, Ito K, Adcock IM. A mechanism of corticosteroid resistance in COPD: inactivation of histone deacetylase. Lancet 2004; 363:7313.
  • 10
    Ito K, Lim S, Caramori G, Chung F, Barnes PJ, Adcock IM. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 15:111012.
  • 11
    Bhavsar P, Hew M, Khorasani N et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared to non-severe asthma. Thorax 2008; 63:78490.
  • 12
    Hew M, Bhavsar P, Torrego A et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006; 174:13441.
  • 13
    Kent L, Smyth L, Plumb J et al. Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N′-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504). J Pharmacol Exp Ther 2009; 328:45868.
  • 14
    Executive summary: global strategy for the diagnosis, management and prevention of COPD. 2008. Available at: (accessed 19 January 2009).
  • 15
    Keatings VM, Collins PD, Scot DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:5304.
  • 16
    Wilkinson TMA, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:10905.
  • 17
    Standiford TJ, Kunkel SL, Rolfe MW, Evanoff HL, Allen RM, Strieter MR. Regulation of human alveolar macrophage- and blood monocyte-derived IL-8 by prostaglandin and dexamethasone. Am J Respir Cell Mol Biol 1992; 6:7581.
  • 18
    Linden M, Brattsand R. Effects of a corticosteroid, budesonide on alveolar macrophage and blood monocyte secretion of cytokines: differential sensitivity of GM-CSF, IL-1β and IL-6. Pulm Pharmacol 1994; 7:437.
  • 19
    Berkman N, Jose PJ, Williams TJ, Schall TJ, Barnes PJ, Chung KF. Corticosteroid inhibition of macrophage inflammatory protein-1α in human monocytes and alveolar macrophages. Am J Phsiol 1995; 269:44352.
  • 20
    Zetterlund A, Linden M, Larsson K. Effects of β2-agonists and budesonide on interleukin-1β and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages. J Asthma 1998; 35:56573.
  • 21
    Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nature 2006; 6:4455.
  • 22
    Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000; 55:60313.
  • 23
    Smith SJ, Fenwick PS, Nicholson AG et al. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 2006; 149:393404.
  • 24
    Kent L, Smyth L, Clayton C et al. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 2008; 42:20516.
  • 25
    Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol 2007; 179:6097106.
  • 26
    Brown GP, Iwamoto GK, Monick MMM, Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol 1989; 256:2604.
  • 27
    Yamaguchi E, Okazaki N, Itoh A, Abe S, Kawakami Y, Okuyama H. Interleukin 1 production by alveolar macrophages is decreased in smokers. Am Rev Respir Dis 1989; 140:397402.
  • 28
    Yamaguchi E, Itoh A, Abe S et al. Release of tumour necrosis factor-α from human alveolar macrophages is decreased in smokers. Chest 1993; 103:47983.
  • 29
    Soliman DM, Twigg HL III. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 1992; 263:4718.
  • 30
    Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M. Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med 1998; 92:9227.
  • 31
    Birell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco smoke on key signalling pathways in innate immune response in lung macrophages. J Cell Physiol 2008; 214:2737.
  • 32
    Löfdahl JM, Cederlund K, Nathell L, Eklund A, Skold CM. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema. Eur Respir J 2005; 25:27581.